After months of investigations, millions of dollars, hundreds of interviews, and panic over potential impeachment, the Mueller investigation finally ended.

Now that the investigation was over, analysts began to note that some sectors could see a boost, as the President turns back to focusing on policy. Some of those sectors include infrastructure, defense, and even cannabis legalization.

In fact, part of Trump’s 2019 budget proposal suggested scaling back restrictive language that has kept Washington D.C. from legalizing and regulating the sale of recreational marijuana. He’s also asking the public to submit comments to help change the U.S. position on a potential reclassification.

Potential legalization could fire up the voter base, considering that 61% of Americans are in favor of legalization. 

Even Congress wants it legalized. 

The Marijuana Justice Act, for example, could legalize marijuana and wipe out any criminal possession charges from American records, according to Rolling Stone. 

Sen. Ron Wyden introduced S. 420, which could legalize and regulate marijuana on a federal level. Known as the Marijuana Revenue and Regulation Act, it would de-schedule marijuana and remove it from the Controlled Substances Act (CSA). 

Now, even the U.S. FDA is moving to act.

The FDA just announced it will start discussing regulatory framework for the use of CBD in consumer products, including foods and beverages, next month.

Controversial or not, the cannabis story cannot be ignored by investors.

Some of the best ways to trade the opportunity is with cannabis ETFs, including:

ETFMG Alternative Harvest ETF (MJ)

---

The End of a Prohibition
Learn How Average Americans are Becoming Marijuana Millionaires!
GET THE FULL REPORT HERE!

---

The ETFMG Alternative Harvest ETF (MJ) offers investors access to the Canadian and global marijuana sector. The fund tracks an index of stocks across the globe that are engaged in the legal cultivation, production, marketing or distribution of cannabis products for either medical or nonmedical purposes. MJ also holds stocks of companies that trade or produce tobacco or tobacco products, or fertilizers, plant foods, pesticides or growing equipment for cannabis or tobacco. In addition, the fund can hold pharmaceutical companies that produce, market or distribute drug products that use cannabinoids.

The Horizons Marijuana Life Sciences Index ETF (HLMSF)

The ETF seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry.  It has holdings in Aurora Cannabis, Canopy Growth, Aphria Inc. Cronos Group, and CannTrust Holdings.

As many of us are aware, ETFs offer us more for less.

If we were to buy the top pot stocks individually, we’d pay more than the cost of the ETF. For example, if we were to buy 100 shares of CGC, it would cost $4,347.  And we’d only own CGC. 

If we were to buy 100 shares of the HMLSF ETF, it would cost us $1,627 and we’d be offered the opportunity to diversify among its many holdings.

Bonus Report: Turn a Small Stake into a Fortune: 

A new earth-shattering government announcement could completely change the legalization of marijuana - forever. In fact, thanks to this historic legislation, tiny pot stocks trading for under $5 are getting set to double, triple, or quadruple. In an exclusive interview with Money Morning, pot stock expert Michael Robinson shares all the good news - including details on five tiny weed stocks that could potentially turn a small stake into $100,000. CLICK HERE TO CONTINUE.